Actigraphic Study of Tremor before and after Treatment with Zonisamide in Patients with Parkinson�

来源 :2013百奥泰波兰重大疾病临床峰会 | 被引量 : 0次 | 上传用户:fdgbh54g45g44
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  In Parkinsons disease (PD)、 resting tremor, postural tremor, or both often occur as initial symptoms.Levodopa and anticholinergic drugs have been used to manage tremor in PD.However, zonisamide (ZNS) an anticonvulsant, was reported to have beneficial effects especially for "wearing-off" symptoms in patients with PD.Miwa et al reported that ZNS significantly suppressed tremor in an experimental rat model of PD.On the basis of these findings.ZNS has been used since 2009 to manage tremor in Japanese patients with PD.We have previously used actigraphy to quantitatively evaluate tremor in patients with PD and essential tremor.An actigraph is a motion-sensing apparatus that can detect three-dimensional motor counts of 0.01 G or more.In this study, we quantitatively evaluated tremor by actigraphy before and after treatment with ZNS in PD patients in order to objectively assess whether ZNS is useful for the management of tremor in PD.
其他文献
ObjectivePatient reported outcomes are important for clinical practice and research and should reflect what patients perceive as important.The objective of this study was to develop and preliminarily
会议
The treatment of Breast Cancer has evolved from the radical Halstead surgical treatment without any adjuvant treatment to the present breast conservation and adjuvant treatment with chemoradiation.The
会议
It has been widely observed that levels of plasma α1,3fucosyltransferase encoded by the FUT6gene are significantly elevated in patients with various cancers1 and that the absence of this enzyme is fai
会议
The importance of cytokines as regulators of the immune response to infection, injury or inflammation has long been recognized.There is now a rapidly growing understanding of their importance in cance
会议
70 percent of people with Alzheimers disease live at home from the onset of the disease until their death.They are taken care of by their closest relatives-spouses, partners or adult children.In my pr
会议
The drug discovery for disease-modifying agents in Alzheimer disease (AD) is facing a failure of clinical trials with drugs based on two driving hypotheses, i.e.the cholinergic and amyloidogenic hypot
会议
Citicoline inhibits apoptosis associated with cerebral ischemia and in several models of neurodegeneration has been able to potentiate neuroplasticity.It is a natural precursor of phospholipid synthes
会议
Cognitive and behavioural impairments accompanying motor neuron disease (MND) have been reported since the early 20th century.Typically, these changes can be associated with a dysexecutive syndrome or
会议
Transthyretin (TTR) is a protective molecule in Atzheimers Disease (AD), binds A-Beta peptide inhibiting its aggregation and toxicity.TTR is early decreased in the cerebrospinal fluid and sera of AD p
会议
Current studies have provided valuable evidence that Parkinsons disease (PD) is closely associated with olfactory loss and that the use of olfactory testing is regarded as one of the potential screeni
会议